Skip to content

Author

Yang Huang

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

SU5, a Stable Auraptene Analog, Ameliorates Metabolic Dysfunction-Associated Steatohepatitis Through Modulation of the FXR Signaling Pathway.

Metabolic Dysfunction-Associated Steatohepatitis (MASH), a metabolic liver disease severely threatening public health, is characterized by hepatic steatosis, inflammatory infiltration, and fibrotic progression. Currently, there is still a lack of specific therapeutic approaches for MASH in clinical practice. Auraptene...

Fen Wen, Jing Chen, Lei Zhu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.